wire - news in brief

Greater well-being may help reduce the risk of memory loss in middle age, according to a study published in the journal Aging & Mental Health , based on a follow-up of more than 10,000 people over the age of 50 over a 16-year period.

Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumours from a simple blood sample.

When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the arteries and cardiovascular health. Now, a study led by the University of Barcelona and the University of Oregon presents a new therapeutic tool capable of regulating blood cholesterol levels and thus opening up new perspectives in the fight against atherosclerosis caused by the accumulation of lipid plaques in the artery walls.

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date.

Universidad Carlos III de Madrid (UC3M) is coordinator on MultiX, a European scientific project involving seventeen research centres and technology companies from seven countries, which aims to revolutionize future 6G communication networks by transforming their design and operation.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy , which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.

A study led by the University of Barcelona and the Spanish National Research Council-s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19.

Research staff from the Universitat de València (UV), the INCLIVA Health Research Institute, the Hospital Clínic Universitari of Valencia, and the Centre for Biomedical Research Centre Network in Men

Research on human-centered indoor climate for health centres UC3M participates in the HumanIC project The European scientific project HumanIC, in which Universidad Carlos III de Madrid (UC3M) is part

The Research Institute on Social Welfare Policy (Polibienestar) of the Universitat de València has presented the results of the European project InAdvance, which aims to improve the quality of life of patients with complex chronic non-oncological diseases.

Researchers from the universities of Valencia (UV), Miguel Hernández (UMH), Rey Juan Carlos (URJC) and ESIC have published a study confirming the benefits of implementing an online intervention progra

The University of Valencia (UV) and the INCLIVA Health Research Institute of the University Clinical Hospital of Valencia have conducted a study to analyse the effect of the cytokine LIGHT, a molecule that may help reduce the severity of atherosclerotic disease.

A study by the Rare Respiratory Diseases research group of the University of Valencia (UV) and the INCLIVA Health Research Institute, the La Fe Health Research Institute and the CEU-Cardenal Herrera University explains the molecular foundations of primary ciliary dyskinesia (DCP).

Ángela Vidal Verdù and Paola Corbín Agustí, researchers at the Institute of Integrative Systems Biology (I2SysBio), a joint centre of the University of Valencia (UV) and the Spanish National Researc

A research team from the Universitat de València, the Universitat Politècnica de València, the CIBER areas of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), and Neurodegenerative Diseases (CIBERNED) and the Research Centre -Príncipe Felipe- (CIPF) has developed a new probe to detect senescent cells in urine, which would help to monitor and better understand ageing-related processes and establish new strategies to reverse the degenerative processes associated with ageing.

The educational program to promote learning and scientific vocations in biotechnology and genetics Amgen TransferCiència has started its fifth edition in the Valencian Community this February (2023-2024 academic year).

The Environmental and Biomedical Virology group of the Institute of Integrative Systems Biology (I2SysBio), a joint centre of the University of Valencia and the Higher Council for Scientific Research